ATE539057T1 - Verfahren zur herstellung von disubstituiertem piperidin und zwischenprodukten davon - Google Patents

Verfahren zur herstellung von disubstituiertem piperidin und zwischenprodukten davon

Info

Publication number
ATE539057T1
ATE539057T1 AT08870986T AT08870986T ATE539057T1 AT E539057 T1 ATE539057 T1 AT E539057T1 AT 08870986 T AT08870986 T AT 08870986T AT 08870986 T AT08870986 T AT 08870986T AT E539057 T1 ATE539057 T1 AT E539057T1
Authority
AT
Austria
Prior art keywords
derivative
action
acid derivative
hydroxyimino
formula
Prior art date
Application number
AT08870986T
Other languages
English (en)
Inventor
Alain Priour
Alain Bonnet
Gilles Oddon
Alain Mazurie
Original Assignee
Novexel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novexel filed Critical Novexel
Application granted granted Critical
Publication of ATE539057T1 publication Critical patent/ATE539057T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32Oximes
    • C07C251/34Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/38Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT08870986T 2007-09-14 2008-09-12 Verfahren zur herstellung von disubstituiertem piperidin und zwischenprodukten davon ATE539057T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0706449A FR2921060B1 (fr) 2007-09-14 2007-09-14 Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires
PCT/FR2008/001280 WO2009090320A1 (fr) 2007-09-14 2008-09-12 Procede de preparation d'une piperidine disubstituee et intermediaires

Publications (1)

Publication Number Publication Date
ATE539057T1 true ATE539057T1 (de) 2012-01-15

Family

ID=39428023

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08870986T ATE539057T1 (de) 2007-09-14 2008-09-12 Verfahren zur herstellung von disubstituiertem piperidin und zwischenprodukten davon

Country Status (9)

Country Link
US (2) US8288553B2 (de)
EP (1) EP2200983B1 (de)
JP (1) JP5421265B2 (de)
CN (1) CN102056901B (de)
AT (1) ATE539057T1 (de)
CA (1) CA2699438C (de)
ES (1) ES2380098T3 (de)
FR (1) FR2921060B1 (de)
WO (1) WO2009090320A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2951171A1 (fr) 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
US8772490B2 (en) 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
SI2657234T1 (sl) * 2010-12-22 2017-06-30 Meiji Seika Pharma Co., Ltd. Derivat optično-aktivnega diazabiciklooktana in metoda za njegovo izdelavo
KR20140004114A (ko) * 2011-03-31 2014-01-10 가부시키가이샤 가네카 환상 아민 화합물의 제조법
KR102143660B1 (ko) 2011-06-17 2020-08-11 화이자 안티-인펙티브스 에이비 트랜스-7-옥소-6-(술포옥시)-1,6-디아자비시클로[3,2,1]옥탄-2-카르복스아미드 및 그의 염을 포함하는 헤테로시클릭 화합물의 제조 방법
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
US9505761B2 (en) 2011-12-02 2016-11-29 Fedora Pharmaceuticals Inc. Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
US8969570B2 (en) 2012-03-30 2015-03-03 Cubist Pharmaceuticals, Inc. Beta-lactamase inhibitors
US8916709B2 (en) 2012-03-30 2014-12-23 Cubist Pharmaceuticals, Inc. 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
TW201343645A (zh) 2012-03-30 2013-11-01 Cubist Pharm Inc 1,3,4-□二唑及1,3,4-噻二唑β-內醯胺酶抑制劑
KR20150003777A (ko) 2012-03-30 2015-01-09 큐비스트 파마슈티컬즈 인코포레이티드 이속사졸 β-락타마제 억제제
RU2693898C2 (ru) 2012-05-30 2019-07-05 Мейдзи Сейка Фарма Ко., Лтд. НОВЫЙ ИНГИБИТОР бета-ЛАКТАМАЗЫ И СПОСОБ ЕГО ПОЛУЧЕНИЯ
UA111925C2 (uk) 2012-12-11 2016-06-24 Федора Фармасьютікалз Інк. БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ
BR112015021332B1 (pt) 2013-03-08 2020-06-30 Wockhardt Limited sal de sódio de ácido (2s, 5r)-6-benzilóxi-7-oxo-1,6-diaza-biciclo [3.2.1] octano-2-carboxílico e sua preparação
US9120795B2 (en) 2013-03-14 2015-09-01 Cubist Pharmaceuticals, Inc. Crystalline form of a β-lactamase inhibitor
DK3050883T3 (da) 2013-09-24 2020-05-25 Meiji Seika Pharma Co Ltd Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter
US9120796B2 (en) 2013-10-02 2015-09-01 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
EP3613740A1 (de) 2013-10-08 2020-02-26 Meiji Seika Pharma Co., Ltd. Herstellungsverfahren für einen diazabicyclooctanderivat
RU2732129C2 (ru) 2014-12-05 2020-09-11 Мейдзи Сейка Фарма Ко., Лтд. Способ производства кристаллов производного диазабициклооктана и стабильного лиофилизированного препарата
WO2017136254A1 (en) * 2016-02-04 2017-08-10 Merck Sharp & Dohme Corp. Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agents
CN107540600B (zh) * 2016-06-28 2019-07-09 新发药业有限公司 一种阿维巴坦中间体生产废液的回收利用方法
CN107540601B (zh) * 2016-06-28 2019-07-19 新发药业有限公司 5r-苄氧氨基哌啶-2s-甲酸酯及其草酸盐的便捷制备方法
CN106699756B (zh) * 2016-12-30 2019-10-29 淄博鑫泉医药技术服务有限公司 β内酰胺酶抑制剂阿维巴坦的合成方法
CN109400521B (zh) * 2017-08-18 2020-05-08 新发药业有限公司 一种改进的5r-苄氧氨基哌啶-2s-甲酸酯、其草酸盐的制备方法
CN109956941B (zh) 2017-12-25 2020-08-04 新发药业有限公司 一种阿维巴坦的简便制备方法
CN109970625B (zh) 2017-12-28 2021-02-26 新发药业有限公司 一种5r-苄氧氨基哌啶-2s-甲酸或其衍生物的制备方法
CN114206851B (zh) * 2019-04-26 2025-02-11 默沙东有限责任公司 可用于制备(2s,5r)-7-氧代-n-哌啶-4-基-6-(硫酸基)-1,6-二氮杂双环[3.2.1]辛烷-2-甲酰胺的中间体的制备方法
CN110498762B (zh) * 2019-08-28 2020-10-27 山东安信制药有限公司 一种(2s,5r)-5-[(苄氧基)氨基]-哌啶-2-甲酸乙酯的合成方法
EP4146650B1 (de) 2020-09-01 2026-01-21 Ningxia Academy of Agriculture and Forestry Sciences Beta-lactamase-hemmer und ihre herstellung
US12410166B2 (en) 2021-05-07 2025-09-09 Ningxia Academy Of Agriculture And Forestry Sciences Sulfonylamidine substituted compounds and their use as beta-lactamase inhibitors
CN114989169A (zh) * 2022-07-04 2022-09-02 哈药集团技术中心 一种阿维巴坦钠的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5059377A (de) * 1973-10-04 1975-05-22
JPS63162666A (ja) * 1986-12-26 1988-07-06 Asahi Chem Ind Co Ltd アミノオキシ酢酸誘導体およびその製造方法
JPH0393762A (ja) * 1989-09-04 1991-04-18 Wako Pure Chem Ind Ltd 4‐ハロゲノ‐2‐アルコキシイミノ‐3‐オキソ脂肪酸の製造方法
FR2812635B1 (fr) 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
US6399793B1 (en) * 2000-08-16 2002-06-04 Bristol-Myers Squibb Company Process for the preparation of α' chloroketones
FR2825705B1 (fr) * 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2833596B1 (fr) 2001-12-14 2005-02-18 Aventis Pharma Sa Procede de preparation de derives d'echinocandine
FR2835186B1 (fr) * 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
FR2848210B1 (fr) * 2002-12-06 2007-10-19 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
US7439253B2 (en) 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
JP3935126B2 (ja) * 2003-09-24 2007-06-20 雅裕 亀田 装飾用灯具
US7396934B2 (en) 2003-11-17 2008-07-08 Youssef El-Ahmad Process for preparing 3-fluoroquinolines
JP2007126358A (ja) * 2004-01-20 2007-05-24 Fujiyakuhin Co Ltd フェニルアラニン誘導体

Also Published As

Publication number Publication date
US20130012712A1 (en) 2013-01-10
EP2200983B1 (de) 2011-12-28
CN102056901A (zh) 2011-05-11
JP2010539147A (ja) 2010-12-16
US20100197928A1 (en) 2010-08-05
HK1145324A1 (en) 2011-04-15
FR2921060B1 (fr) 2012-06-15
WO2009090320A1 (fr) 2009-07-23
ES2380098T3 (es) 2012-05-08
CA2699438A1 (en) 2009-07-23
US8288553B2 (en) 2012-10-16
CN102056901B (zh) 2014-09-03
JP5421265B2 (ja) 2014-02-19
CA2699438C (en) 2016-11-22
FR2921060A1 (fr) 2009-03-20
EP2200983A1 (de) 2010-06-30

Similar Documents

Publication Publication Date Title
ATE539057T1 (de) Verfahren zur herstellung von disubstituiertem piperidin und zwischenprodukten davon
AR039150A1 (es) Piridinoilpiperidinas como agonistas de 5-ht1f
DE60311756D1 (de) Phenyl pyridine-iridium Metal-Komplexverbindungen für organische elektroluminizierende Vorrichtung, Verfahren zur Herstellung der Verbindungen und organische elektroluminizierende Vorrichtung die diese Verbindungen verwendet
NO20074895L (no) Isoksazolin derivat og ny fremgangsmate for fremstilling derav
IS2060B (is) Aðferð til framleiðslu á hreinu sítalóprami
WO2009153178A3 (en) Aryl ketone as mri
ATE373643T1 (de) Als fungizide geeignete 2- pyridinylcycloalkylcarbonsäureamidderivate
NO20076000L (no) Aminosyrederivater
WO2009127949A8 (en) 4- [3- (aryloxy) benzylidene] -3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
UA90188C2 (ru) Способ выделения кислот из реакционных смесей и способ получения триамидов тиофосфорной кислоты
ATE513801T1 (de) Verfahren zur synthese von propargylatierten aminoindanderivativen
ATE483679T1 (de) Substituierte cyclohexylessigsäure-derivate
WO2008081726A1 (ja) アミド又はラクタムの製造法
ATE441627T1 (de) Verfahren zur herstellung von valsartan
ATE437883T1 (de) Verfahren zur trennung von zirkonium und hafnium
DE602006004186D1 (de) VERFAHREN ZUR HERSTELLUNG EINER NICHTAROMATISCHEN L-AMINOSÄURE UNTER VERWENDUNG EINES BAKTERIUMS DERRESSION DES csrA-GENS
ATE510844T1 (de) Cycloalkylcarbonylaminosäure-derivat und herstellungsverfahren dafür
EP1862446A3 (de) Verfahren zur Herstellung von enantiomerenangereicherten Hydroxylaminderivaten
DE50310200D1 (de) Verfahren zur herstellung von aminoalkoxybenzylaminen und aminoalkoxybenzonitrilen als zwischenprodukte
AR057451A1 (es) Metodos para preparar derivados de acido glutamico
ATE555093T1 (de) Verfahren zur herstellung einer (s)-1-alkyl-2i,6i-pipecoloxylididverbindung
DE602005013007D1 (de) Verfahren zur herstellung von lactonen
ATE402157T1 (de) Verfahren zur herstellung von mycophenolatmofetil
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung
ATE473966T1 (de) Verfahren zur herstellung eines carbonsäureamidderivats